(Q37724176)

22 August 2017

1 reference

title

Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage (English)

1 reference

22 August 2017

Ines A Pieper

1

1 reference

22 August 2017

Martin Bertau

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Expert Opinion on Drug Metabolism & Toxicology

22 August 2017

published in

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

747-760

1 reference

Estimating the cost of new drug development: is it really 802 million dollars?

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Predicting undesirable drug interactions with promiscuous proteins in silico

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Cytochrome P450-mediated metabolism in the human gut wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Biotransformation of malachite green by the fungus Cunninghamella elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Biotransformation of the antimelanoma agent betulinic acid by Bacillus megaterium ATCC 13368.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

The screening of selected microorganisms for use as models of mammalian drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Computational approaches to modeling drug transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Progress in simulation modelling for pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Early prediction of drug metabolism and toxicity: systems biology approach and modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Present and future in vitro approaches for drug metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Gut microbiota: a factor in energy regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Bacterial diversity in the human gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

The gut flora as a forgotten organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Intestinal responses to xenobiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

The gastrointestinal microbiota as a site for the biotransformation of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Review article: prebiotics in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Effects of caffeine on stereoselectivities of high cell density biotransformations of cyclic beta-keto esters with Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Stress induces the translocation of cutaneous and gastrointestinal microflora to secondary lymphoid organs of C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Variation in human intestinal microbiota with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Bacteria in the pathogenesis of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Probiotics: potential pharmaceutical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Modulation of the human gut microflora towards improved health using prebiotics--assessment of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Prebiotics and resistance to gastrointestinal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Headspace solid-phase microextraction-gas chromatography-mass spectrometry determination of the characteristic flavourings menthone, isomenthone, neomenthol and menthol in serum samples with and without enzymatic cleavage to validate post-offence al

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Hydrogen sulphide: a bacterial toxin in ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Formulation strategies for absorption windows

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Metabolism of drugs and other xenobiotics in the gut lumen and wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Microbial ecology of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Recombinant Saccharomyces cerevisiae expressing P450 in artificial digestive systems: a model for biodetoxication in the human digestive environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Assessing the zearalenone-binding activity of adsorbent materials during passage through a dynamic in vitro gastrointestinal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Bioavailability of ferulic acid is determined by its bioaccessibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Application of support vector machines to in silico prediction of cytochrome p450 enzyme substrates and inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Mechanism-based modeling of complex biomedical systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Machine learning techniques for in silico modeling of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Model evaluation for glycolytic oscillations in yeast biotransformations of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Biosimulation of drug metabolism--a yeast based model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Functional profiling of the Saccharomyces cerevisiae genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Transcriptional regulatory networks in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Genetic and physical maps of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Overview of the yeast genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

In vivo analysis of metabolic dynamics in Saccharomyces cerevisiae: II. Mathematical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Full-scale model of glycolysis in Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Control analysis for autonomously oscillating biochemical networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Methods for predicting human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Around the growth phase transition S. cerevisiae's make-up favours sustained oscillations of intracellular metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Can yeast glycolysis be understood in terms of in vitro kinetics of the constituent enzymes? Testing biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Gut microbiota: a potential new territory for drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

Sustained oscillations in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003769859

10.1517/17425251003769859

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference